Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Biotech Investing
Portage Issues Common Shares and Warrants in Settlement of SalvaRx Loan Note Obligations Biotech Investing
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million Medical Device Investing
Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Compound TFC-1067 Biotech Investing
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis Biotech Investing
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test Medical Device Investing
Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests Medical Device Investing
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 Medical Device Investing
Bristol Myers Squibb Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia in Adult Patients with Moderate to Severe Ulcerative Colitis Biotech Investing
Nutritional High Announces Approval of the Proposed Amendments to the 10% Senior Unsecured Convertible Debentures and Extension of the Term of the 12% Senior Secured Convertible Debentures Cannabis Investing News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
